|   | 
        
            
              
                
                  
                    | Associate Professor Xin Liang | 
                   
                  
                     | 
                   
                  
                     | 
                   
                 
                                                           
                 
                  
                    | 发布时间:2019-11-29   访问次数:792   作者: | 
                   
                 
                
                
                  
                     Contact Information
 Office:Room 633, Researching Building 18 Email: xin.liang@yazhouwm.com Office Phone: +86 21 6425 2262 Office Fax: +86 21 6425 2262 
 Education 2012.03 Ph.D.Biochemical Engineering, East China University of Science&Technology, Shanghai, P. R. China  2007.06 B.Sc.Bioengineering, East China University of Science&Technology, Shanghai, P. R. China 
 Professional Experience 2016-now   Associate Professor School of Pharmacy, East China Universtiy of Science and Technology, Shanghai, P. R. China 2015-2016   Instructor School of Pharmacy, East China Universtiy of Science and Technology, Shanghai, P. R. China 2012-2015   Postdoctoral Fellow Aflac Cancer and Blood Disorders Center, Dept of Pediatrics, School of Medicine, Emory University, Atlanta, GA, USA 
 Research Interests Publication Xu K*, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan G, Wang J, Li W, Cao Y, Shen X, Zhang J, Liang X*, Yin P*. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop.Molecular Therapy. 2019, 27(10):1810-1824. Qi Y, Chen W, Liang X, Xu K*, Gu X, Wu F, Fan X, Ren S, Liu J, Zhang J, Li R, Liu J*, Liang X*. Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction. Journal of Hematology & Oncology. 2018, 11(1):117.  Liang X, Chen W, Shi H, Gu X, Li Y, Qi Y, Xu K*, Zhao A*, Liu J*. PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing. Cell Death & Disease. 2018, 9:569.  Liang X, Shi H, Yang L, Qiu C, Lin S, Qi Y, Li J*, Zhao A*, Liu J*. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells. Br J Cancer. 2017, 116(7):903-911.  Liang X, Wang J, Chen W, Ma X, Wang Y, Nagao N, Weng W*, Huang J*, Liu J*. Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model. Biomed Pharmacother. 2017;95:275-286.  Xu K, Chen G, Li X, Wu X, Chang Z, Xu J, Zhu Y, Yin P, Liang X*, Dong L*. MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling. Sci Rep. 2017, 7:41718.  Lin S, Yang L, Shi H, Du W, Qi Y, Qiu C, Liang X*, Shi W*, Liu J*. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy. Int J Biochem Cell Biol. 2017;87: 54-68.  Chen W, Ma X, Zhang P, Li Q, Liang X*, Liu J*. MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages. Exp Cell Res. 2017, 350(2):318-26.  Chen W1, Liang X1, Syed AK, Jessup P, Church WR, Ware J, Josephson CD, Li R*. Inhibiting GPIbα shedding preserves post-transfusion recovery and hemostatic function of platelets after prolonged storage. Arterioscler Thromb Vasc Biol. 2016, 36(9):1821-8.  Liang X, Syed AK, Russell SR, Ware J, Li R*. Dimerization of glycoprotein Ib is not sufficient to induce platelet clearance. J Thromb Haemost. 2016,14: 381-6.  Li Q1, Liang X1, Wang Y, Meng X, Xu Y, Cai S, Wang Z*, Liu J*, Cai G*. miR-139-5p Inhibits the Epithelial- Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2. Sci Rep. 2016, 6: 27157.  Zou F, Mao R, Yang L, Lin S, Lei K, Zheng Y, Ding Y, Zhang P, Cai G*, Liang X*, Liu J*. Targeted deletion of miR-139-5p activates MAPK, NF-kB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J. 2016, 283(8): 1438-52.  Lei K, Du W, Lin S, Yang L, Xu Y, Gao Y, Xu B, Tan S, Xu Y, Qian X, Liang X*, Liu J*. 3B, a novel photosensitizer, inhibits glycolysis and inflammation via miR-155-5p and breaks the JAK/STAT3/SOCS1 feedback loop in human breast cancer cells. Biomed Pharmacother. 2016, 82: 141-50.  Zheng Y, Yin G, Le V, Zhang A, Chen S, Liang X*, Liu J*. Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy. Int J Biol Sci. 2016, 12(1): 120-32.  Lin S, Lei K, Du W, Yang L, Shi H, Gao Y, Yin P*, Liang X*, Liu J*. Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism. Int J Biochem Cell Biol. 2016, 71:24-34.  Mao R, Zou F, Yang L, Lin S, Li Y, Ma M, Yin P*, Liang X*, Liu J*. The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling. Int J Biochem Cell Biol. 2015, 69: 153-61.  Liang X, Russell SR, Estelle S, Jones LH, Cho S, Kahn ML, Berndt MC, Bunting ST, Ware J, Li R*. Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost. 2013, 11(12): 2155-62. 
  
  | 
                   
                 
              
             
         
        
		        
        
		
		
       
         | 
          | 
       
      |